Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marika Mende

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|December 22, 2018
Parvovirus B19 InfectionMarika Mende, Katja Sockel
BMC Cancer|February 9, 2013
Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced populationMarika Mende, Karolin Trautmann, Anke Rentsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Siltuximab for Multicentric Castleman Disease-LetterRaphael Teipel, Rainer Ordemann, Ulrike Proske, et al.
Frontiers in Genetics|January 24, 2022
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal CancerSebastian Stasik, Marika Mende, Caroline Schuster, et al.
The Lancet. Oncology|November 17, 2018
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trialUwe Platzbecker, Jan Moritz Middeke, Katja Sockel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|December 22, 2018
Parvovirus B19 InfectionMarika Mende, Katja Sockel
BMC Cancer|February 9, 2013
Patients' perspectives on palliative chemotherapy of colorectal and non--colorectal cancer: a prospective study in a chemotherapy- experienced populationMarika Mende, Karolin Trautmann, Anke Rentsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Siltuximab for Multicentric Castleman Disease-LetterRaphael Teipel, Rainer Ordemann, Ulrike Proske, et al.
Frontiers in Genetics|January 24, 2022
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal CancerSebastian Stasik, Marika Mende, Caroline Schuster, et al.
The Lancet. Oncology|November 17, 2018
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trialUwe Platzbecker, Jan Moritz Middeke, Katja Sockel, et al.
Pageof 1